Published in J Endocrinol on May 01, 1978
Intrauterine nutrition: its importance during critical periods for cardiovascular and endocrine development. J Physiol (1999) 1.38
Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of Type 2 diabetes mellitus. Biochem J (2000) 0.97
Maturation of stimulus recognition and insulin secretion during tissue culture of fetal pancreatic islets. Trans Am Clin Climatol Assoc (1979) 0.75
Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42
An analysis of birth weight by gestational age of infants born in England and Wales, 1967 to 1971. J Obstet Gynaecol Br Commonw (1974) 3.44
Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ (1991) 2.69
Knemometry in assessment of linear growth. Arch Dis Child (1987) 2.39
Effects of neonatal hypoglycaemia on the nervous system: a pathological study. J Neurol Neurosurg Psychiatry (1967) 2.36
Cations and the secretion of insulin from rabbit pancreas in vitro. J Physiol (1968) 2.33
The role of sodium and potassium in insulin secretion from rabbit pancreas. J Physiol (1968) 2.27
Investigation of suspected growth hormone deficiency. On behalf of the Health Services Human Growth Hormone Committee. Arch Dis Child (1982) 2.23
The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia (1967) 2.17
A new syndrome of congenital hypoparathyroidism, severe growth failure, and dysmorphic features. Arch Dis Child (1991) 2.17
Effect of glucose on plasma glucagon, growth hormone, and insulin in exchange transfusion. Arch Dis Child (1972) 2.13
Prediction and management of nocturnal hypoglycaemia in diabetes. Arch Dis Child (1987) 2.02
Effects of fetal exposure to diazoxide in man. Arch Dis Child (1972) 2.02
Persistent impairment of insulin secretory response to glucose in adult rats after limited period of protein-calorie malnutrition early in life. Diabetes (1987) 1.96
Gamma-M deficiency predisposing to meningococcal septicaemia. Br Med J (1967) 1.88
Pathological changes in the nervous system in severe neonatal hypoglycaemia. Lancet (1966) 1.80
Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun (1989) 1.79
Control of carbohydrate metabolism in the fetus and newborn. Br Med Bull (1975) 1.70
Transient neonatal diabetes mellitus in sibs. Arch Dis Child (1970) 1.58
Intra-abdominal neuroectodermal tumour of childhood with divergent differentiation. Histopathology (1991) 1.57
Which children should have growth hormone therapy? Lancet (1986) 1.51
Fat absorption by small babies fed two filled milk formulae. Arch Dis Child (1975) 1.49
Plasma glucose, non-esterified fatty acid, insulin and growth hormone response to glucagon in the newborn. Clin Sci (1967) 1.47
Chronic myelomonocytic leukaemia. Br J Haematol (1975) 1.45
Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J (1996) 1.42
Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems. Circulation (1997) 1.42
Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation (2001) 1.41
Cellular development of some human organs before birth. Arch Dis Child (1972) 1.39
Assessment of bone age: a comparison of the Greulich and Pyle, and the Tanner and Whitehouse methods. Clin Radiol (1986) 1.38
Human growth hormone (UK). Arch Dis Child (1979) 1.37
Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. J Pharmacol Exp Ther (1987) 1.31
Limit of fetal viability. Lancet (1984) 1.31
The sodium pump and insulin secretion. Biochim Biophys Acta (1967) 1.29
The interaction of various inhibitors and stimuli of insulin release studied with rabbit pancreas in vitro. Biochem J (1969) 1.26
The 'Sport-tester': a device for monitoring the free running test. Arch Dis Child (1986) 1.22
Free running asthma screening test. Arch Dis Child (1988) 1.21
Bi-functional action of transforming growth factor-beta on DNA synthesis in early passage human fetal fibroblasts. J Cell Physiol (1986) 1.21
Growth hormone 1985. Br Med J (Clin Res Ed) (1985) 1.20
Crying vital capacity. Measurement of neonatal lung function. Arch Dis Child (1976) 1.18
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension (2000) 1.17
Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes. Circulation (1997) 1.16
Insulin as a growth factor. Pediatr Res (1985) 1.15
Ultrastructure of skin window cells in normal subjects. J Anat (1982) 1.15
Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child (1970) 1.15
Height and lymphoblastic leukaemia. Arch Dis Child (1983) 1.14
Vectors of Death. The Archaeology of European Contact. Ann F. Ramenofsky. University of New Mexico Press, Albuquerque, 1988. xvi, 300 pp., illus. $27.50. Science (1988) 1.13
Nuclear morphology and the ultrastructural localization of deoxyribonucleic acid synthesis during interphase. J Cell Sci (1969) 1.13
Genetic linkage studies of X-linked hypophosphataemic rickets in a Saudi Arabian family. Clin Endocrinol (Oxf) (1992) 1.12
Cations and the secretion of insulin. Biochim Biophys Acta (1968) 1.11
Control of fetal lung development in the rabbit. Arch Dis Child (1973) 1.10
Glucagon, insulin, and growth hormone response to exchange transfusion in premature and term infants. Arch Dis Child (1972) 1.07
Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun (1987) 1.05
Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Br J Pharmacol (1993) 1.02
Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol (2001) 1.02
Bone marrow culture studies in refractory cytopenia and 'smouldering leukaemia'. Br J Haematol (1977) 1.01
The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun (1992) 1.01
Renin and aldosterone response in human newborns to acute change in blood volume. Arch Dis Child (1978) 1.01
Antimicrobial activity of silicone rubber used in hydrocephalus shunts, after impregnation with antimicrobial substances. J Clin Pathol (1981) 1.00
Blood glucose, plasma insulin and growth hormone response to hyperglycaemia in the newborn. Clin Sci (1966) 1.00
Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells. Regul Pept (1993) 0.99
Ultrastructural localization of nucleic acid synthesis in human blood cells. Nature (1968) 0.99
Growth failure secondary to moyamoya syndrome. Arch Dis Child (1990) 0.98
Aetiology of transient neonatal diabetes. Arch Dis Child (1971) 0.97
Sex determination of ancient human skeletons using DNA. Am J Phys Anthropol (1996) 0.96
Colour flow mapping in the diagnosis of the calf deep vein thrombosis. Clin Radiol (1993) 0.96
Plasma glucagon, thyrotropin, growth hormone and insulin response to cold exposure in the human newborn. Acta Paediatr Scand (1972) 0.96
Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol (1993) 0.96
The angiotensin AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells. FEBS Lett (1992) 0.95
Growth hormone in short, slowly growing children and those with Turner's syndrome. Arch Dis Child (1987) 0.95
Binding characteristics and vascular effects of various angiotensin II antagonists. J Cardiovasc Pharmacol (1990) 0.95
Sitting heights in Sheffield, 1985: have standards changed? Acta Paediatr Scand (1987) 0.95
Control of insulin secretion in the developing pancreatic rudiment. Dev Biol (1975) 0.95
Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteins. Eur J Pharmacol (1991) 0.94
When are we diagnosing growth hormone deficiency? Arch Dis Child (1986) 0.93
Clinical pharmacology of gentamicin in the newborn infant. Arch Dis Child (1972) 0.93
Fetal distress and birth scores in newborn infants. Arch Dis Child (1975) 0.93
Fetal growth control: the role of insulin and related peptides. Clin Endocrinol (Oxf) (1984) 0.92
Changes in leg length and height during treatment with somatotropin. Arch Dis Child (1989) 0.92
Accumulation of Cu, Zn, Mn, Cr and Co in the human liver before birth. Biol Neonate (1972) 0.92
Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem Biophys Res Commun (1990) 0.91
Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects. Eur J Clin Pharmacol (1997) 0.90
Incorporation of [3H]thymidine by isolated fetal myoblasts and fibroblasts in response to human placental lactogen (HPL): possible mediation of HPL action by release of immunoreactive SM-C. J Cell Physiol (1985) 0.90
Interaction between isolated amphibian skin and insulin. Arch Int Physiol Biochim (1969) 0.90
The stimulation of insulin release by essential amino acids from rabbit pancreas in vitro. J Endocrinol (1970) 0.90
Examination of skin window preparations by transmission electron microscopy. J Clin Pathol (1980) 0.89
The nutritional cost of measles in Africa. Arch Dis Child (1986) 0.89
Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children. J Clin Pathol (1979) 0.89
Growth and metabolic and hormonal profiles during transpyloric and nasogastric feeding in preterm infants. Acta Paediatr Scand (1981) 0.89
Insulin release from human foetal pancreas in response to glucose, leucine and arginine. J Endocrinol (1972) 0.89
Metabolic and hormonal effects of glucagon infusion in erythroblastotic infants. Arch Dis Child (1973) 0.89
Placental lactogen and growth hormone receptors in human fetal tissues: relationship to fetal plasma human placental lactogen concentrations and fetal growth. J Clin Endocrinol Metab (1988) 0.89
Synthesis and biological activity of seventeen analogues of human insulin. Hoppe Seylers Z Physiol Chem (1979) 0.88
Clinical experience of somatrem: UK preliminary report. Acta Paediatr Scand Suppl (1986) 0.88
Growth hormone regulation of somatomedin C/insulin-like growth factor I production and DNA replication in fetal rat islets in tissue culture. Diabetes (1987) 0.88
Synthesis and biological activity of two disulphide bond isomers of human insulin: [A7-A11,A6-B7-cystine]- and [A6-A7,A11-B7-cystine]insulin (human). Hoppe Seylers Z Physiol Chem (1978) 0.88
Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein. J Clin Endocrinol Metab (1994) 0.88
Stimulation of insulin secretion in vitro by essential aminoacids. Lancet (1969) 0.88
Growth hormone deficiency presenting under age 2 years. Arch Dis Child (1984) 0.87
Removal of endogenous leptin from the circulation by the kidney. Int J Obes Relat Metab Disord (1997) 0.87
Cultured fetal rat myoblasts release peptide growth factors which are immunologically and biologically similar to somatomedin. J Cell Physiol (1984) 0.87